T1	Outcomes 379 446	bioavailability of diflunisal-naproxen fixed-dose combination (FDC)
T2	Outcomes 539 566	dissolution behavior of FDC
T3	Outcomes 1058 1081	diflunisal and naproxen
T4	Outcomes 1172 1215	Cmax, AUC0-t, AUC0-∞, tmax, and t1/2 were
T5	Outcomes 1337 1366	of Cmax, AUC0-t, and AUCt-∞
